# Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase

> **NCT04195347** · PHASE1,PHASE2 · RECRUITING · sponsor: **St. Jude Children's Research Hospital** · enrollment: 42 (estimated)

## Conditions studied

- Acute Pancreatitis

## Interventions

- **DRUG:** CM4620

## Key facts

- **NCT ID:** NCT04195347
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-09-04
- **Primary completion:** 2027-01
- **Final completion:** 2029-01
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2026-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04195347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04195347, "Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04195347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*